Impact of Atorvastatin Versus Rosuvastatin on 25 Hydroxy Vitamin D Levels in Patients With Acute Coronary Syndrome

PHASE4RecruitingINTERVENTIONAL

Enrollment

152

Participants

Timeline

Start Date

January 5, 2025

Primary Completion Date

January 1, 2026

Study Completion Date

January 1, 2026

Conditions

Acute Coronary Syndromes

Interventions

DRUG

Rosuvastatin 20 mg/day

Rosuvastatin 20 mg / Day for 24 weeks

DRUG

Atorvastatin 40 mg

Atorvastatin 40mg / Day for 24 weeks

Trial Locations (1)

RECRUITING

King Edward Medical University, Lahore

All Listed Sponsors

lead

King Edward Medical University

OTHER